Aptar Pharma has announced the first application for an eye care product for its patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) for the treatment of dry eye with the launch of Vismed Multi.
Aptar Pharma has worked closely with Swiss eye care specialist TRB Chemedica to improve patient safety, achieving dosing accuracy and maintaining product stability on the ophthalmic spray device.
Dry eye patients have to use lubricant eye drops on a regular basis. Most of these patients are elderly and often experience eye irritation or allergic responses with preserved formulations.
Aptar Pharma’s OSD system is the result of more than 10 years of development for the delivery of preservative-free ophthalmic solutions.
TRB Chemedica’s new Vismed Multi are patented, sterile, hypotonic lubricant eye drops with a formulation of 0.18% hyaluronic acid and essential ions calcium and magnesium potassium. Each product contains 10ml of solution, which is the equivalent of more than 250 drops and remains sterile for up to three months after first use.
Aptar Pharma says its OSD system offers a number of benefits to the Vismed Multi, including:
- intuitiveness of a squeezable container;
- user friendliness for all adult age groups due to a low actuation force;
- precise and reproducible drop ejection;
- ergonomic and pocket size design.
Aptar Pharma is a developer of drug delivery systems. It is part of the Aptargroup family of companies that includes Aptar Beauty + Home and Aptar Food + Beverage.
